Record Display for the EPA National Library Catalog


Main Title Postnatal Effects of Hexachlorobenzene (HCB) on Cardiac Lactic Dehydrogenase (LDH) and Creatine Kinase (CK) Isozymes in CD-1 Mice.
Author Courtney, K. D. ; Andrews, J. E. ; Grady, M. A. ; Ebron, M. T. ;
CORP Author Health Effects Research Lab., Research Triangle Park, NC. ;Northrop Services, Inc., Research Triangle Park, NC.
Year Published 1984
Report Number EPA/600/J-84/255;
Stock Number PB85-176618
Additional Subjects Toxicology ; Bioassay ; Chlorine organic compounds ; Phosphorus organic compounds ; Hydroxy acids ; Mice ; Laboratory animals ; Reprints ; Benzene/hexachloro ; Dehydrogenase/lactate ; Kinases(Phosphorylating)/creatine
Library Call Number Additional Info Location Last
NTIS  PB85-176618 Some EPA libraries have a fiche copy filed under the call number shown. 07/26/2022
Collation 8p
Pregnant CD-1 mice were treated with hexachlorobenzene (HCB) by gavage at doses of 0, 1, 10 and 50 mg HCB/kg body weight on days 6-17 of gestation and studied on day 1 or 21 postpartum (pp). Hearts of the dams and pups were assayed for lactic dehydrogenase (LDH) and creatine kinase (CK) activities and isozyme profiles. LDH and CK activities and CK isozyme profiles were not affected in the dams by HCB treatment, but isozyme LDH-5 was significantly depressed and isozyme LDH-3 significantly increased at the 50 mg/kg dose of HCB on day 1 pp. Hearts of the pups were studied on days 1, 8, 10, 15 and 21 pp. The 50 mg/kg dose level resulted in a statistically significant increased mortality in the pups. The mortality at the other doses showed a dose-related effect. LDH and CK activities and CK isozyme profiles were not affected by HCB exposure in utero. The only isozyme affected was LDH-5 with a statistically significant increase in the 50 mg/kg dose group on day 21 pp.